These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2140088)

  • 1. The role of hyperglycaemia-induced alterations of antithrombin III and factor X activation in the thrombin hyperactivity of diabetes mellitus.
    Ceriello A; Quatraro A; Marchi E; Barbanti M; Dello Russo P; Lefebvre P; Giugliano D
    Diabet Med; 1990 May; 7(4):343-8. PubMed ID: 2140088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans.
    Ceriello A; Giugliano D; Quatraro A; Marchi E; Barbanti M; Lefèbvre P
    Diabetologia; 1990 Mar; 33(3):163-7. PubMed ID: 2184068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low molecular weight heparin restores antithrombin III activity from hyperglycemia induced alterations.
    Ceriello A; Marchi E; Palazzni E; Quatraro A; Giugliano D
    Diabete Metab; 1990; 16(2):86-92. PubMed ID: 2196192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
    Cerskus AL; Birchall KJ; Ofosu FA; Hirsh J; Blajchman MA
    Can J Biochem Cell Biol; 1984 Oct; 62(10):975-83. PubMed ID: 6509363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of factor Xa in determining the procoagulant activity of whole-blood clots.
    Eisenberg PR; Siegel JE; Abendschein DR; Miletich JP
    J Clin Invest; 1993 May; 91(5):1877-83. PubMed ID: 8486759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the COOH-terminal region of antithrombin III. Evidence that the COOH-terminal region of the inhibitor enhances the reactivity of thrombin and factor Xa with the inhibitor.
    Nishioka J; Suzuki K
    J Biol Chem; 1992 Nov; 267(31):22224-9. PubMed ID: 1331047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.
    Griffith MJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5460-4. PubMed ID: 6577437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin III.
    Walker FJ; Esmon CT
    J Biol Chem; 1979 Jul; 254(13):5618-22. PubMed ID: 447671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin generation and inactivation in the presence of antithrombin III and heparin.
    Lindhout T; Baruch D; Schoen P; Franssen J; Hemker HC
    Biochemistry; 1986 Oct; 25(20):5962-9. PubMed ID: 3790498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of PGI2 on the inactivation of thrombin, factor Xa, and plasmin by antithrombin-III and heparin.
    Blaskó G
    Prostaglandins; 1979 Jul; 18(1):3-9. PubMed ID: 160589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostasis activation markers in acute renal failure.
    Stefanidis I; Frank D; Maurin N
    Ren Fail; 1998 Jan; 20(1):147-55. PubMed ID: 9509568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of markers of activated coagulation in antithrombin III deficient subjects.
    Demers C; Ginsberg JS; Henderson P; Ofosu FA; Weitz JI; Blajchman MA
    Thromb Haemost; 1992 May; 67(5):542-4. PubMed ID: 1519214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and functional study of antithrombin III in newborn infants.
    McDonald MM; Hathaway WE; Reeve EB; Leonard BD
    Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies of the turnover of dog antithrombin III. Study of 131I-labelled antithrombin protease complexes.
    Leonard B; Bies R; Carlson T; Reeve EB
    Thromb Res; 1983 Apr; 30(2):165-77. PubMed ID: 6868021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'.
    Sørensen PJ; Sas G; Petó I; Blaskó G; Kremmer T; Samu A
    Thromb Res; 1982 May; 26(3):211-9. PubMed ID: 7112514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procoagulant activity and intimal dysfunction in IDDM.
    Myrup B; Rossing P; Jensen T; Gram J; Kluft C; Jespersen J
    Diabetologia; 1995 Jan; 38(1):73-8. PubMed ID: 7744231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
    Scully MF; Kakkar VV
    Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.